🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 20 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/08/2003 31,74 31,92 29,94 30,66 -2,67% 6,24% 40.550
05/08/2003 30,54 32,34 30,30 31,50 +4,17% 6,68% 91.983
04/08/2003 29,64 30,54 28,50 30,24 +0,80% 6,88% 63.300
01/08/2003 29,94 30,24 28,80 30,00 +0,81% 4,81% 43.250
31/07/2003 29,88 30,60 28,80 29,76 +0,20% 6,02% 44.367
30/07/2003 30,72 31,26 28,56 29,70 -2,75% 8,79% 58.050
29/07/2003 31,14 31,50 30,12 30,54 -0,78% 4,43% 36.850
28/07/2003 31,02 32,04 30,66 30,78 -1,54% 4,45% 47.383
25/07/2003 30,48 32,04 29,52 31,26 -0,38% 8,27% 59.917
24/07/2003 32,82 33,30 30,48 31,38 -4,39% 8,59% 66.983
23/07/2003 32,10 33,06 31,74 32,82 +2,24% 4,11% 43.883
22/07/2003 35,10 35,70 30,30 32,10 -6,14% 15,38% 135.467
21/07/2003 35,34 35,58 33,90 34,20 -3,06% 4,75% 39.650
18/07/2003 34,86 35,82 34,62 35,28 +1,38% 3,44% 23.333
17/07/2003 35,22 35,76 34,62 34,80 -2,03% 3,24% 52.383
16/07/2003 37,08 37,38 35,10 35,52 -3,74% 6,15% 46.767
15/07/2003 37,08 37,20 36,30 36,90 +2,50% 2,43% 131.183
14/07/2003 36,18 36,30 34,68 36,00 +1,18% 4,48% 95.117
11/07/2003 35,82 36,30 35,16 35,58 +0,34% 3,18% 50.583
10/07/2003 37,44 37,50 35,28 35,46 -3,43% 5,93% 57.750
09/07/2003 36,96 37,20 36,00 36,72 +2,68% 3,25% 109.500
08/07/2003 35,16 36,00 34,56 35,76 +1,88% 4,10% 92.450
07/07/2003 35,10 35,94 34,62 35,10 +0,17% 3,76% 60.033
03/07/2003 35,04 35,40 34,56 35,04 -1,02% 2,40% 31.650
02/07/2003 36,48 36,48 34,50 35,40 -1,99% 5,43% 77.833
01/07/2003 35,46 36,90 34,50 36,12 -1,15% 6,77% 89.517
30/06/2003 37,14 37,20 35,10 36,54 +2,35% 5,65% 211.883
27/06/2003 36,36 37,14 35,28 35,70 +0,34% 5,12% 185.950
26/06/2003 34,62 35,94 34,32 35,58 +3,67% 4,68% 93.817
25/06/2003 35,10 35,10 33,60 34,32 -2,05% 4,27% 85.850